Linfoma mediastinal em gato com vírus da leucemia felina / Mediastinal lymphoma in a cat with feline leukemia virus

Background: Mediastinal lymphoma occurs at a high incidence in cats positive for feline leukemia virus (FeLV). It is a malignant lymphocytic neoplasm that may trigger clinical signs such as dyspnea, apathy, regurgitation, and weight loss. The objective of this work is to report a case of mediastinal lymphoma associated with FeLV in a cat, and describe the clinical, pathological, diagnostic, and therapeutic aspects that can help the diagnosis and treatment of this disease. Case: A 3-year-old male neutered cat weighing 4.6 kg, positive for FeLV, and with a history of dyspnea and hyporexia was referred to a private veterinary clinic in the city of Caxias do Sul, RS, Brazil. The only alteration found at the clinical examination was a muffled sound during lung auscultation. Radiographs of the thorax revealed the presence of pleural effusion; after drainage of the fluid, a mass located in the mediastinal area became radiographically observable. An analysis of the effusion fluid showed high cellularity characterized by a markedly pleomorphic population of individual round cells consistent with lymphocytes. Small lymphocytes with a high nucleus:cytoplasm ratio, round nucleus, condensed chromatin, and inconspicuous nucleoli were observed, along with medium and large lymphocytes. The medium and large lymphocytes were characterized by a variably increased nucleus:cytoplasm ratio and a scant to moderate cytoplasm exhibiting moderate to intense basophilia and, occasionally, vacuoles. The nuclei were round, idented, or irregular; most of them were located eccentrically and contained coarse to finely granular chromatin. Nucleoli varied from single to multiple, round to angular, and central to peripheral and prominent. Macronucleoli and marked anisonucleosis were also observed, as well as binucleated cells and rare multinucleated cells. The conclusion was that it was a case of neoplastic effusion caused by a lymphoma. After an appointment with an oncologist, a chemotherapy protocol was established. The treatment of choice was CHOP, a combination of cyclophosphamide (20 mg/kg orally), doxorubicin (1 mg/kg intravenously), vincristine (0.5 mg/m2 intravenously), and prednisolone with a regressive dose starting at 2 mg/kg. The patient underwent 4 rounds of chemotherapy, and received a maintenance treatment thereafter. The patient's condition remained stable for 390 days without relevant clinical or hematological alterations. Discussion: The diagnosis of mediastinal lymphoma was established by associating clinical finings, laboratory exams, and radiographic findings. Exams of utmost importance to reach this diagnosis were the thoracic radiography, which revealed the presence of a mass in the thorax, and the cytopathological analysis of the effusion fluid, as round cell neoplasms are easily dissociated. Young cats are the group most affected by FeLV, and mediastinal lymphoma is considered the most prevalent type of lymphoma in this species. The most common clinical sign is dyspnea; however, other signs such as apathy, weight loss, regurgitation (due to pressure on the esophagus), and Horner's syndrome (owing to pressure on the thoracic sympathetic innervation) may also occur. This disease is treated with chemotherapy, with CHOP frequently used as the chemotherapeutic protocol. The good therapeutic response for a longer time than the average estimated by studies on the prognostic of this disease indicates that a correct diagnosis along with an assertive approach and the cooperation of the tutor are essential in cases of mediastinal lymphoma.

LOPH and D-MHC in the treatment of FeLV associated acute leukemia in a cat

Background: Bone marrow primary malignancies are denominated leukemias, classified as myeloid or lymphoid, according to the cell lineage, and acute or chronic, according to the cell´s state of maturation. In cats, acute lymphoid leukemiais the most common form, especially in regions endemic for feline leukemia virus and / or feline immunodeficiency virus.A new treatment protocol for lymphomas, called LOPH, was described for animals with FeLV persistent viremia. Thisstudy aimed to report a case of a cat presenting with FeLV associated acute leukemia and treated with the LOPH protocol,and, in the rescue phase, a modification of the D-MAC protocol, denominated D-MHC.Case: A 4-year-old mixed breed intact queen was attended due to lethargy and inappetence. The patient did not present anyrelevant abnormalities in the clinical exam and complementary exams were performed including complete blood count,biochemical profile, SNAP Feline Triple Test, chest radiographs and abdominal ultrasound. Imaging tests and biochemicalvalues were unremarkable, but the patient presented a reagent result for FeLV and severe leukocytosis due to lymphocytosis. The morphological evaluation of the blood smear revealed the presence of blasts, in a concentration greater than 20%of the nucleated cells, which allowed the characterization of a leukemic state, probably lymphoid. First-line treatmentwas based on the LOPH protocol, including Lomustine, Vincristine, Prednisolone and Doxorubicin, in four-week cycles.Nevertheless, during the third cycle, 66 days after the institution of this protocol, the patient presented a febrile conditionalong with marked leukocytosis due to lymphocytosis, confirming leukemia recurrence. A rescue attempt was performedwith a modification of the D-MAC protocol, originally consisting of the combination of dexamethasone, melphalan, actinomycin-D and cytarabine, but with replacement of actinomycin-D by doxorubicin, and therefore denominated D-MHC....

LOPH and D-MHC in the treatment of FeLV associated acute leukemia in a cat

Background: Bone marrow primary malignancies are denominated leukemias, classified as myeloid or lymphoid, according to the cell lineage, and acute or chronic, according to the cell´s state of maturation. In cats, acute lymphoid leukemiais the most common form, especially in regions endemic for feline leukemia virus and / or feline immunodeficiency virus.A new treatment protocol for lymphomas, called LOPH, was described for animals with FeLV persistent viremia. Thisstudy aimed to report a case of a cat presenting with FeLV associated acute leukemia and treated with the LOPH protocol,and, in the rescue phase, a modification of the D-MAC protocol, denominated D-MHC.Case: A 4-year-old mixed breed intact queen was attended due to lethargy and inappetence. The patient did not present anyrelevant abnormalities in the clinical exam and complementary exams were performed including complete blood count,biochemical profile, SNAP Feline Triple Test, chest radiographs and abdominal ultrasound. Imaging tests and biochemicalvalues were unremarkable, but the patient presented a reagent result for FeLV and severe leukocytosis due to lymphocytosis. The morphological evaluation of the blood smear revealed the presence of blasts, in a concentration greater than 20%of the nucleated cells, which allowed the characterization of a leukemic state, probably lymphoid. First-line treatmentwas based on the LOPH protocol, including Lomustine, Vincristine, Prednisolone and Doxorubicin, in four-week cycles.Nevertheless, during the third cycle, 66 days after the institution of this protocol, the patient presented a febrile conditionalong with marked leukocytosis due to lymphocytosis, confirming leukemia recurrence. A rescue attempt was performedwith a modification of the D-MAC protocol, originally consisting of the combination of dexamethasone, melphalan, actinomycin-D and cytarabine, but with replacement of actinomycin-D by doxorubicin, and therefore denominated D-MHC....(AU)

Distúrbio compulsivo em cadela da raça Border Collie / Compulsive disorder in Border Collie bitch

Background: Compulsive disorders are excessive and repetitive behaviors that jeopardize the quality of life of both animaland guardian. It generally affects dogs between 6 and 36 months of age and its etiology is associated to stress, anxiety andgenetic predisposition. Clinical manifestations are the usual behaviors of the dog, but overly and inappropriately done.Diagnosis is based on a history of repetitive behavior and on clinical and complementary exams to discard other diseases.The aim of this study is to report a case of compulsive disorder in a female Border Collie dog, including diagnostic andtherapeutic approaches.Case: A 5-month-old, female, Border Collie dog was presented to Uberaba’s Veterinary Hospital owing to a chasingshadows behavior that started as a playtime activity but intensified to the point of becoming a repetitive and excessive act,followed by self-trauma and excessive barking. Clinical examination showed lesions in nasal planum region. No alterationswere observed on neurological examination apart from the chasing of shadows that also happened in the consultation room.Therefore, since there were no other findings on clinical and neurological exams, and since the manifestation occurredas a response to environmental stimuli (presence of shadows), it was established a presumptive diagnosis of compulsivedisorder. Treatment with trazodone chlorhydrate was performed, and it was indicated ovariohysterectomy, a follow-upwith a professional behaviorist and trainer and environment modifications. After a fortnight, it was observed a discreetimprovement of the clinical signs, hence a second anxiolytic, clomipramine, was added to the treatment. Approximately3 months after the beggining of therapy, there was improvement of the animal’s clinical picture...

Distúrbio compulsivo em cadela da raça Border Collie / Compulsive disorder in Border Collie bitch

Background: Compulsive disorders are excessive and repetitive behaviors that jeopardize the quality of life of both animaland guardian. It generally affects dogs between 6 and 36 months of age and its etiology is associated to stress, anxiety andgenetic predisposition. Clinical manifestations are the usual behaviors of the dog, but overly and inappropriately done.Diagnosis is based on a history of repetitive behavior and on clinical and complementary exams to discard other diseases.The aim of this study is to report a case of compulsive disorder in a female Border Collie dog, including diagnostic andtherapeutic approaches.Case: A 5-month-old, female, Border Collie dog was presented to Uberabas Veterinary Hospital owing to a chasingshadows behavior that started as a playtime activity but intensified to the point of becoming a repetitive and excessive act,followed by self-trauma and excessive barking. Clinical examination showed lesions in nasal planum region. No alterationswere observed on neurological examination apart from the chasing of shadows that also happened in the consultation room.Therefore, since there were no other findings on clinical and neurological exams, and since the manifestation occurredas a response to environmental stimuli (presence of shadows), it was established a presumptive diagnosis of compulsivedisorder. Treatment with trazodone chlorhydrate was performed, and it was indicated ovariohysterectomy, a follow-upwith a professional behaviorist and trainer and environment modifications. After a fortnight, it was observed a discreetimprovement of the clinical signs, hence a second anxiolytic, clomipramine, was added to the treatment. Approximately3 months after the beggining of therapy, there was improvement of the animals clinical picture...(AU)

The effects of separate and combined use of PGF2α and GnRH hormones and the addition of beta-carotene on fertility parameters in dairy cows with ovarian cysts

Background: Ovarian cysts are commonly observed pathologies, which interfere with normal cyclic activity and adversely affect fertility in cows. Beta-carotene is effective in the reduction of reproductive problems by inducing the natural defence mechanisms of the body. There are several methods that can be used for the treatment of ovarian cysts. The separate and combined use of GnRH and PGF2α commonly uses in the treatment of ovarian cysts. Therefore, in the presented study the effects of Beta-carotene (βC) addition for the treatment of ovarian cysts either with GnRH solely or GnRH and PGF2α in combination on the fertility parameters of dairy cows were investigated.Materials, Methods & Results: Seventy-six Holstein Friesian cows having ovarian cysts diagnosed by ultrasonography (USG) were divided into three groups. Cows in Group I (GI, n = 27), were injected with GnRH (Buserelin acetate, 5 mL, im), PGF2α (Tiaprost-trometamol, 5 mL, im) and βC (20 mL/cow, into 4 regions by im route). In Group II (GII, n = 25) GnRH (Buserelin acetate, 5 mL, im) and PGF2α (Tiaprost-trometamol, 5mL, im) were administrated while GnRH (Buserelin acetate, 5 mL, im) solely in Group III (GIII, n = 24). Cysts were monitored via USG, and blood samples were collected on the on day of treatment (day 0) and on the 7th and 14th days following the administrations. Cows shoving oestrous were inseminated and pregnancy diagnoses were performed on the 40th day following insemination. Treatment results showed that there were statistically no significant differences between GI and GII (P > 0.05). Only numerical difference obtained in time from therapy to pregnancy and overall pregnancy index (P > 0.05). Overall pregnancy rate (85 %), first service pregnancy rates (40 %) and overall pregnancy index (2.11) in GI were found significantly higher than GIII (53.3 %; 20 %; 4.12) [P 0.05).[...]

The effects of separate and combined use of PGF2α and GnRH hormones and the addition of beta-carotene on fertility parameters in dairy cows with ovarian cysts

Background: Ovarian cysts are commonly observed pathologies, which interfere with normal cyclic activity and adversely affect fertility in cows. Beta-carotene is effective in the reduction of reproductive problems by inducing the natural defence mechanisms of the body. There are several methods that can be used for the treatment of ovarian cysts. The separate and combined use of GnRH and PGF2α commonly uses in the treatment of ovarian cysts. Therefore, in the presented study the effects of Beta-carotene (βC) addition for the treatment of ovarian cysts either with GnRH solely or GnRH and PGF2α in combination on the fertility parameters of dairy cows were investigated.Materials, Methods & Results: Seventy-six Holstein Friesian cows having ovarian cysts diagnosed by ultrasonography (USG) were divided into three groups. Cows in Group I (GI, n = 27), were injected with GnRH (Buserelin acetate, 5 mL, im), PGF2α (Tiaprost-trometamol, 5 mL, im) and βC (20 mL/cow, into 4 regions by im route). In Group II (GII, n = 25) GnRH (Buserelin acetate, 5 mL, im) and PGF2α (Tiaprost-trometamol, 5mL, im) were administrated while GnRH (Buserelin acetate, 5 mL, im) solely in Group III (GIII, n = 24). Cysts were monitored via USG, and blood samples were collected on the on day of treatment (day 0) and on the 7th and 14th days following the administrations. Cows shoving oestrous were inseminated and pregnancy diagnoses were performed on the 40th day following insemination. Treatment results showed that there were statistically no significant differences between GI and GII (P > 0.05). Only numerical difference obtained in time from therapy to pregnancy and overall pregnancy index (P > 0.05). Overall pregnancy rate (85 %), first service pregnancy rates (40 %) and overall pregnancy index (2.11) in GI were found significantly higher than GIII (53.3 %; 20 %; 4.12) [P < 0.05]. No significant difference was observed in progesterone (P4) levels between the groups (P > 0.05).[...](AU)

Avaliação da infectividade parasitária a Lutzomyia longipalpis por xenodiagnóstico em cães tratados para leishmaniose visceral naturalmente adquirida / Evaluation of parasite infectivity for Lutzomyia longipalpis by xenodiagnosis in dogs treated for natural visceral leishmaniasis

O efeito de um protocolo quimioterápico multidrogas contra a leishmaniose visceral (LV) canina, sobre a capacidade de transmissão de Leishmania infantum ao vetor, foi analisado por meio de xenodiagnóstico. Trinta e cinco cães naturalmente infectados foram avaliados antes e durante o tratamento com a combinação de metronidazol, cetoconazol e alopurinol a cada três meses por até um ano. Em cada avaliação, os cães foram individualmente submetidos ao xenodiagnóstico e quantificação da carga parasitária por PCR quantitativa. O tratamento foi eficaz em bloquear a transmissibilidade parasitária do cão para o flebotomíneo (p= 0,011) nos cães avaliados. Houve significante correlação entre recuperação clínica e infectividade: cães com melhora clínica mais evidente apresentaram menores chances de transferir L. infantum ao Lutzomyia longipalpis via xenodiagnóstico (r=0,528, p= 0,002). Esses resultados demonstram que o tratamento canino com o protocolo proposto pode representar uma alternativa ao sacrifício de cães no Brasil como medida de controle da doença, uma vez que as drogas utilizadas não são aplicadas ao tratamento da LV humana em áreas endêmicas.(AU)

The outcome of a multidrug chemotherapeutic protocol against canine visceral leishmaniasis (VL) has been evaluated for its effect on dogs' capacity of transferring Leishmania infantum to sand flies by xenodiagnosis. Thirty-five naturally infected dogs were examined before and during treatment with a combination of metronidazole, ketoconazole, and allopurinol, at every three months up to one year. For each evaluation, treated dogs were individually submitted to xenodiagnosis and quantitative PCR to quantify parasite load in sand flies. The treatment was effective in blocking parasite transmission from host to sand flies (p=0.011) in the assessed dogs. There was a significant correlation between clinical improvement and sand fly infectivity: dogs that achieved better clinical conditions showed a lower chance of L. infantum transference to vector by xenodiagnosis (r=0.528, p=0.002). These results demonstrate that the treatment of dogs with the proposed protocol may represent an alternative to dog culling in Brazil for disease control, since these drugs are not used for treating human VL in endemic areas.(AU)

Avaliação da infectividade parasitária a Lutzomyia longipalpis por xenodiagnóstico em cães tratados para leishmaniose visceral naturalmente adquirida / Evaluation of parasite infectivity for Lutzomyia longipalpis by xenodiagnosis in dogs treated for natural visceral leishmaniasis

O efeito de um protocolo quimioterápico multidrogas contra a leishmaniose visceral (LV) canina, sobre a capacidade de transmissão de Leishmania infantum ao vetor, foi analisado por meio de xenodiagnóstico. Trinta e cinco cães naturalmente infectados foram avaliados antes e durante o tratamento com a combinação de metronidazol, cetoconazol e alopurinol a cada três meses por até um ano. Em cada avaliação, os cães foram individualmente submetidos ao xenodiagnóstico e quantificação da carga parasitária por PCR quantitativa. O tratamento foi eficaz em bloquear a transmissibilidade parasitária do cão para o flebotomíneo (p= 0,011) nos cães avaliados. Houve significante correlação entre recuperação clínica e infectividade: cães com melhora clínica mais evidente apresentaram menores chances de transferir L. infantum ao Lutzomyia longipalpis via xenodiagnóstico (r=0,528, p= 0,002). Esses resultados demonstram que o tratamento canino com o protocolo proposto pode representar uma alternativa ao sacrifício de cães no Brasil como medida de controle da doença, uma vez que as drogas utilizadas não são aplicadas ao tratamento da LV humana em áreas endêmicas.(AU)

The outcome of a multidrug chemotherapeutic protocol against canine visceral leishmaniasis (VL) has been evaluated for its effect on dogs' capacity of transferring Leishmania infantum to sand flies by xenodiagnosis. Thirty-five naturally infected dogs were examined before and during treatment with a combination of metronidazole, ketoconazole, and allopurinol, at every three months up to one year. For each evaluation, treated dogs were individually submitted to xenodiagnosis and quantitative PCR to quantify parasite load in sand flies. The treatment was effective in blocking parasite transmission from host to sand flies (p=0.011) in the assessed dogs. There was a significant correlation between clinical improvement and sand fly infectivity: dogs that achieved better clinical conditions showed a lower chance of L. infantum transference to vector by xenodiagnosis (r=0.528, p=0.002). These results demonstrate that the treatment of dogs with the proposed protocol may represent an alternative to dog culling in Brazil for disease control, since these drugs are not used for treating human VL in endemic areas.(AU)

Linfoma digestivo em gato doméstico (Felis catus): relato de caso / Digestive lymphoma in domestic cat (Felis catus): Case report

This study aimed to describe a digestive lymphoma in a female cat with twelve years old, cross breed and negative for feline leukemia (FeLV) and feline immunodeficiency virus (FIV). During physical examination was observed a moderate dehydration and abdominal pain. During transabdominal ultrasound was observed a spleen size increase with anecogenic areas with moderate vascularization, suggestive for tumor. Histopathologic examination of tumor was spleen lymphoma - lymphoblastic lymphoma. Immunohistochemical examination classification was B lymphocytes cells tumor. Chemotherapy with vincristine sulphate and prednisone, followed by total splenectomy was performed. Animal demonstrated improvements after treatment and three months after was diagnosed a liver lymphoma and the owner asks for euthanasia. The present case report shows tnecessity of chemotherapy to control this type of tumor, to increase the quality and patient survival. Digestive lymphoma with high rate of mitosis can be observed in cat with over 10 years old without being associated with infection by FIV or FeLV.

O objetivo do trabalho foi descrever um caso de linfoma digestivo em uma gata de 12 anos de idade, sem raça definida, com sorologia negativa para leucemia felina (FeLV) e imunodeficiência felina (FIV). Durante o exame físico foi observado desidratação moderada e dor abdominal. No exame transabdominal ultrassonográfico foi observado esplenomegalia e áreas anecogênicas dispersas na região do corpo e cabeça esplênica, moderada vascularização, sendo sugestivo a neoplasia. A neoplasia foi classificada como linfoma esplênico, do tipo linfoma linfoblástico. O exame imunofenotípico, classificou o linfoma como linfoma das células B. A neoplasia foi tratada com quimioterapia combinada de sulfato de vincristina e prednisolona, seguida de esplenectomia total. O animal demonstrou melhorias após o tratamento, e três meses após foi diagnosticado linfoma hepático, e o proprietário optou pela eutanásia. Existe a necessidade da terapia antineoplásica no controle do linfoma digestivo, com o objetivo de aumentar a qualidade de vida e sobrevida do paciente. Foi possível observar o linfoma digestivo de grau alto e com alto índice de mitose, em uma gata com idade acima a 10 anos e sem associação à infecção por FIV ou FeLV.

Linfoma digestivo em gato doméstico (Felis catus): relato de caso / Digestive lymphoma in domestic cat (Felis catus): Case report

This study aimed to describe a digestive lymphoma in a female cat with twelve years old, cross breed and negative for feline leukemia (FeLV) and feline immunodeficiency virus (FIV). During physical examination was observed a moderate dehydration and abdominal pain. During transabdominal ultrasound was observed a spleen size increase with anecogenic areas with moderate vascularization, suggestive for tumor. Histopathologic examination of tumor was spleen lymphoma - lymphoblastic lymphoma. Immunohistochemical examination classification was B lymphocytes cells tumor. Chemotherapy with vincristine sulphate and prednisone, followed by total splenectomy was performed. Animal demonstrated improvements after treatment and three months after was diagnosed a liver lymphoma and the owner asks for euthanasia. The present case report shows tnecessity of chemotherapy to control this type of tumor, to increase the quality and patient survival. Digestive lymphoma with high rate of mitosis can be observed in cat with over 10 years old without being associated with infection by FIV or FeLV.(AU)

O objetivo do trabalho foi descrever um caso de linfoma digestivo em uma gata de 12 anos de idade, sem raça definida, com sorologia negativa para leucemia felina (FeLV) e imunodeficiência felina (FIV). Durante o exame físico foi observado desidratação moderada e dor abdominal. No exame transabdominal ultrassonográfico foi observado esplenomegalia e áreas anecogênicas dispersas na região do corpo e cabeça esplênica, moderada vascularização, sendo sugestivo a neoplasia. A neoplasia foi classificada como linfoma esplênico, do tipo linfoma linfoblástico. O exame imunofenotípico, classificou o linfoma como linfoma das células B. A neoplasia foi tratada com quimioterapia combinada de sulfato de vincristina e prednisolona, seguida de esplenectomia total. O animal demonstrou melhorias após o tratamento, e três meses após foi diagnosticado linfoma hepático, e o proprietário optou pela eutanásia. Existe a necessidade da terapia antineoplásica no controle do linfoma digestivo, com o objetivo de aumentar a qualidade de vida e sobrevida do paciente. Foi possível observar o linfoma digestivo de grau alto e com alto índice de mitose, em uma gata com idade acima a 10 anos e sem associação à infecção por FIV ou FeLV.(AU)

Radiographic and histological evaluation of bisphosphonate alendronate and metotrexate effects on rat mandibles inoculated with Walker 256 carcinosarcoma / Avaliação radiográfica e histológica do efeito do bisfosfonato alendronato e do metotrexato na mandíbula de ratos inoculados com carcinossarcoma 256 de Walker

PURPOSE: To investigate the effects of bisphosphosnate alendronate (ALD) and metotrexate (MTX) on an experimental model of Walker 256 carcinosarcoma developed in the oral cavity of rats. METHODS Walker 256 carcinosarcoma cell suspension (0,1 mL) containing 10(6) cell/mL was implanted in the alveoli of the first and second molars. The animals were divided and treated with saline, MTX, ALD, and MTX plus ALD. Later, the animals were sacrificed, the tumors were measured and the mandibles were removed for radiographic and histological analysis. RESULTS: In the control group, the radiographic images demonstrated radioluscency with poorly defined borders, and the microscopic examination revealed tumor infiltration into the peripheral and central regions of the bone. Areas of necrosis were commonly seen. In the treated groups with ALD, associated or not with MTX, the radiographic analysis revealed circumscribed tumor-induced osteolysis and various degrees of radiotransparence; while, histologically, preserved bone trabeculae with osteoid formation was observed among malignant cells. CONCLUSION: The bisphosphonate alendronate exherted an osteoprotective effect and induced bone neoformation on the Walker 256 carcinosarcoma inoculated in rat mandibles. The combination of metotrexate with bisphosphonate alendronate is more successful than treatment with the agents alone in controlling the growth of neoplastic cells and in stimulating reactive new bone. Therefore, this may be an alternative treatment to malignant lesions of maxillaries with osteolysis(AU)

OBJETIVO: Avaliar o efeito do bisfosfonato alendronato (ALD) e do metotrexato (MTX) em modelo do carcinossarcoma 256 de Walker na mandíbula de ratos. MÉTODOS: Uma suspensão de células tumorais do carcinossarcoma 256 de Walker (0,1mL), na concentração de 10(6) células/mL, foi implantada nos alvéolos de ratos previamente abertos por exodontia. Os animais foram divididos em grupos e tratados com salina, MTX, ALD e associação do MTX com ALD. Após o sacrifício, os tumores foram medidos e as mandíbulas removidas para exames radiográfico e histológico. RESULTADOS: No exame radiográfico do grupo controle foi verificada área lítica, sem evidência de reparo na região dos alvéolos, e no microscópico, infiltração óssea periférica e central, de pequenas células tumorais com diversas áreas de necrose. Nos grupos tratados com ALD, associado ou não ao MTX, a análise radiográfica mostrou redução da osteólise tumor-induzida com graus variados de radiotransparência na estrutura óssea; enquanto que, na análise histopatológica, trechos de tecido ósseo preservado, com formação de osteóide em meio a células tumorais foram observados. CONCLUSÃO: O bisfosfonato alendronato exerceu um efeito osteoprotetor e induziu neoformação óssea em mandíbulas de ratos implantadas com células de carcinossarcoma de Walker 256. A combinação do metotrexato com o bisfosfonato alendronato foi mais eficaz que o tratamento com os agentes isoladamente no controle do crescimento das células neoplásicas e na estimulação da formação óssea. Sendo assim, essa associação constitui-se uma alternativa de tratamento das neoplasias malignas dos maxilares com invasão e comprometimento ósseo(AU)

Avaliação algimétrica por estímulo nociceptivo térmico e pressórico em cães pré-tratados com levomepromazina, midazolam e quetamina associados ou não ao butorfanol ou buprenorfina / The algimetry evaluation for thermic and pressoric nociceptive stimulus in pre treated dogs with methotrimeprazine, midazolam and ketamine associated or not with butorphanol or buprenorphine

OBJETIVO: Quantificar a dor em cães sob anestesia dissociativa através de estímulo térmico e pressórico e o período hábil de dois analgésicos opióides. MÉTODOS: Empregaram-se 30 cães alocados em três grupos (n=10), onde os animais de GI receberam levomepromazina e midazolam associado na mesma seringa à quetamina. Os animais de GII receberam o mesmo tratamento de GI porém associado ao butorfanol e por fim os animais de GIII receberam o mesmo tratamento de GI associando-se a buprenorfina. Procedeu se a avaliação paramétrica rotineira, empregando-se, entretanto, a termoalgimetria mensurada em ºC em média de 52ºC e a pressoalgimetria em kg. RESULTADOS: Na termoalgimetria houve diferença significativa em GI nos momentos M0 e M1,e em M4 e M5. Em GII houve diferença em M0, M1, M5 e M6. Em GIII houve diferença entre momentos M0 e M1. Na pressoalgimetria houveram diferenças em GI em diferentes momentos: M0, M2 e M3. Em GII observaram-se diferenças em todos os momentos. Em GIII observaram-se diferenças em M0 e M9. Ocorreram diferenças entre os grupos, sendo o M2 de GII menor que GI e GIII. Já em M4 e M5 de GIII demonstrou-se maior que GI e GII. E na avaliação dos períodos observou-se um período de latência significativamente maior em GI, porém com período hábil e de recuperação menor em relação à GII e GIII. Já a recuperação do tônus postural foi maior em GIII seguido de GII e finalmente de GI. CONCLUSAO: O método empregado para mensuração do estímulo álgico foi eficiente, observando-se um período hábil analgésico de 3 horas para o butorfanol e de 6 horas para a buprenorfina. (AU)